News
FDA okays Italfarmaco’s non-steroidal DMD therapy Duvyzat
Italfarmaco’s oral HDAC inhibitor givinostat has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD), becoming the first non-steroidal option for
